Analystreport

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $3.00 price target on the stoc...

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report